LRRC75A and breast carcinoma: Mechanistically, the LncRNA LRRC75A-AS1 acts as a miR-489-3p ceRNA sponge that antagonizes the activity of miR-489-3p on its target protein ARD1, thereby upregulating ARD1 levels and promoting breast cancer progression, thus offering a potential therapeutic target for breast cancer.